The good the bad and the ugly ASX200 Earnings Season review

The Australian earnings season is in the home stretch, with reports left from just a handful of stocks after reports this week from Fortescue Metals (FMG), Crown (CWN), and Harvey Norman (HVN).


Results overall have been solid. A standout feature of this reporting season has been many companies are flush with cash and have not hesitated to reward shareholders through dividend payments and share buybacks. 

Dividend payments are on track for a record $34bn, which will exceed the August 2019 record of $27bn and over $20bn in buybacks. 

Another noticeable feature has been that lockdowns are weighing on outlook statements. Many companies have elected to provide no guidance, and analysts and investors have been somewhat surprised at the level of caution expressed where guidance statements have been provided. 

This reporting season has also delivered its usual volatility, with stocks rerated sharply higher after a "beat" or punished for a "miss, highlighted by several stocks that moved by more than 10% after delivering reports last week. 

Winners last week included travel stocks such as Flight Centre (FLT) +21%, Webjet (WEB) +17%, and Qantas (QAN) +16.1%. As well as Blackmores (BKL) +20.5% and Nanosonics (NAN) +21.5%. 

Losers last week included Seven Group (SVW) -10.1%, Cochlear (COH) -10.9%, (KGN) -14.7%, Appen (APX) -11% and A2 Milk (A2M) -11%. 

With Sydney's lockdown likely to extend into October and Victoria’s into Mid-September, more downgrades than upgrades are expected to impact the FY22 earning season. 

An excellent example of this is Wesfarmers. Despite delivering a strong FY 2021 outcome last week across its range of businesses, including Bunnings, Officeworks, and Kmart, the share price of Wesfarmers has sagged over 5%, a reflection that ongoing lockdowns will suppress sales.

Nonetheless, the ASX200 is on track to lock in its 11th straight month of gains in August and is up 16.6% in 2021. 

With a roadmap to reopening in NSW in place courtesy of the strong vaccination rate, supportive monetary and fiscal policy, and attractive dividend yields, the preference is to buy a dip in the ASX200 towards 7300, looking for a rally towards 7700 into year-end. 

ASX200 Daily Chart

Source Tradingview. The figures stated areas of August 31st 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation

More from ASX

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.

Open an Account